● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For several months, analysts have been revising their EPS estimates roughly upwards.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● The group usually releases upbeat results with huge surprise rates.
Weaknesses
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 365.03 times its estimated earnings per share for the ongoing year.
● Based on current prices, the company has particularly high valuation levels.
● The company appears highly valued given the size of its balance sheet.